Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2004 | 1 |
2010 | 1 |
2012 | 1 |
2015 | 1 |
2016 | 9 |
2017 | 3 |
2018 | 6 |
2019 | 10 |
2020 | 10 |
2021 | 6 |
2022 | 5 |
2023 | 5 |
2024 | 4 |
Search Results
54 results
Results by year
Overall, the effect's weighted standardized difference in means was -2.046 (95%CI: -3.156 to -0.936; p-value < 0.001). The efficacy of the treatment was observed for animals inoculated with both human glioblastoma or rat glioma cells and for different modes of resveratr
…Overall, the effect's weighted standardized difference in means was -2.046 (95%CI: -3.156 to -0.936; p-value < 0.001). The efficac
…We identified seven factors with negative impact in survival: age above 65 years-old (p < 0.01), ECOG 2-3 (p < 0.01), B symptoms (p = 0.001), bulky disease (p = 0.003), IPI 3-4 (p = 0.001), more than 3 treatment lines (p < 0.01),
…We identified seven factors with negative impact in survival: age above 65 years-old (p < 0.01), ECOG 2-3 (p < 0.01), B
…Histopathological regression from CIN 3 to CIN < 1 was 22.1% (95% CI: 0.6270.967; p-value = 0.024), showing a vaccine efficacy of 23.6% (95% CI; 0.6660.876; p-value < 0.001). DNA clearance was assessed, and the risk of persistent HPV DNA was 23.2% (95% CI: 0.6
…Histopathological regression from CIN 3 to CIN < 1 was 22.1% (95% CI: 0.6270.967; p-value = 0.024), showing a vaccine efficacy of
…